ISIS Pharmaceuticals Posted a Huge Gain – so Who is this Biotech Company?

Jacob Harper |

In the midst of a global market slide, Isis Pharmaceuticals (ISIS) gained a whopping 29.24 percent today to close out at $28.42 a share. This Carlsbad, California biotech company is way up for the year, posting an absolutely staggering 268 percent increase since the beginning of the year. Isis also experienced massive volume, trading 9.78 million shares against an average of 1.54 million. We thought this merited a closer look to see what made ISIS stick out on an otherwise gloomy day for the market.



Isis Pharmaceuticals, Inc., incorporated in January 10, 1989, is engages in antisense technology, which is a new approach to combating genetic disorders. Specifically, the Company's principal activity is to develop and market RNA (RiboNucleicAcid)-based novel drugs to treat important diseases such as cardiovascular diseases, diabetes and asthma. While Isis has yet to have a major success on the market, Isis’ research looks promising, and has investors excited for their future. Isis is set to deliver a report to stockholders on June 25th.

Shares of the stock shot up today after the drug company said an experimental treatment for patients with high triglyceride levels in their blood showed potential. More detailed information on their research is forthcoming later this summer.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Companies

Symbol Name Price Change % Volume
ISIS Isis Pharmaceuticals Inc. n/a n/a n/a 0 Trade
RAX Rackspace Hosting Inc n/a n/a n/a 0 Trade

Comments

Emerging Growth

Invictus MD Strategies Corp

Invictus MD Strategies Corp is engaged in the investment, acquisition and development of synergistic businesses in an effort to increase and sustain growth and value.

Private Markets

iPRO Network, LLC

We provide the platform, tools, and resources to empower individuals and professionals to market desirable goods and services to the public, taking the place of traditional methods of commerce.

The Green Organic Dutchman

The Green Organic Dutchman Ltd. ("TGOD") produces farm grown, organic cannabis for medical use. The company grows its high quality organic cannabis in small batches using craft growing, all natural…